Sign in →

Test Code INS Insulin, Serum

Reporting Name

Insulin, S

Useful For

Diagnosing insulinoma, when used in conjunction with proinsulin and C-peptide measurements

 

Management of diabetes mellitus

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Specimen Type

Serum


Ordering Guidance


Patients on insulin therapy may develop anti-insulin antibodies. These antibodies may interfere in the assay system, causing inaccurate results. In such individuals, measurement of free insulin INSFT / Insulin, Free and Total, Serum should be performed.



Specimen Required


Patient Preparation:

1. Patient should be fasting.

2. For 12 hours before specimen collection do not take multivitamins or dietary supplements containing biotin (vitamin B7), which is commonly found in hair, skin, and nail supplements and multivitamins.

Supplies: Sarstedt 5 mL Aliquot Tube (T914)

Collection Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 1 mL

Collection Instructions:

1. Avoid hemolysis

2. Label specimens with corresponding collection times.

3. Centrifuge and aliquot serum into plastic vial within 2 hours of collection.

Additional Information: If multiple specimens are drawn, send separate order for each specimen.


Specimen Minimum Volume

0.75 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Frozen (preferred) 180 days
  Refrigerated  7 days

Reference Values

2.6-24.9 mcIU/mL

 

For SI unit Reference Values, see https://www.mayocliniclabs.com/order-tests/si-unit-conversion.html

Day(s) Performed

Monday through Friday

Test Classification

This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

CPT Code Information

83525

Clinical Information

Insulin is a hormone produced by the beta cells of the pancreas. It regulates the uptake and utilization of glucose and is also involved in protein synthesis and triglyceride storage.

 

Type 1 diabetes (insulin-dependent diabetes) is caused by insulin deficiency due to destruction of insulin-producing pancreatic islet (beta) cells. Type 2 diabetes (noninsulin-dependent diabetes) is characterized by resistance to the action of insulin (insulin resistance).

 

Insulin levels may be increased in patients with pancreatic beta cell tumors (insulinoma).

Report Available

1 to 3 days

Reject Due To

Gross hemolysis Reject
Gross lipemia OK
Autopsy specimen Reject

Method Name

Electrochemiluminescence Immunoassay (ECLIA)